How does berotralstat dihydrochloride prevent hereditary angioedema attacks?

Berotralstat dihydrochloride inhibits plasma kallikrein, reducing release of bradykinin, which increases vascular permeability and causes swelling attacks in hereditary angioedema due to C1-INH deficiency or dysfunction.